News & Press Releases

Integrity Applications to Present and Exhibit at the 2013 Meeting of the European Association for the Study of Diabetes in Barcelona

September 24th, 2013

Integrity Applications to Present and Exhibit at the 2013 Meeting of the European Association for the Study of Diabetes in Barcelona CEO Avner Gal Will Present Poster on GlucoTrack® DF-F Monitoring Device ASHKELON, Israel – September 24, 2013 — Integrity Applications, Inc. (OTCQB: IGAP), developer of the GlucoTrack® model DF-F non-invasive blood glucose measurement device, […]

Read More Download

Archive

Sign up to our newsletter
To receive occasional news updates

LinkedIn Facebook Twitter

GlucoTrack Model DF-F is intended for use in non-invasive quantitative spot measurement of glucose, for home-use. The GlucoTrack Model DF-F is intended for use by adults (over the age of 18 years old) type 2 diabetic patients, as well as pre-diabetic patients. Medications intake / treatment decisions should not be based only on measurements by GlucoTrack model DF-F. The GlucoTrack Model DF-F is a monitoring device and should not be used for diagnosis.

© 2017 Integrity Applications. All Rights Reserved.